title: ... Fracture prevention. New osteoporosis drug improves patient adherence.
authors.affiliation: McLeod Family Residency Program at McLeod Regional Medical Center, Florence, South Carolina, USA.
authors.forename: Kelly W
authors.initials: KW
authors.lastname: Jones
authors.forename: Reamer L
authors.initials: RL
authors.lastname: Bushardt
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000069448:Denosumab; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D055118:Medication Adherence; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D053245:RANK Ligand / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053245:RANK Ligand; D000069448:Denosumab